Chanchal Kumar

Head Bioinformatics and Disease Understanding at Grünenthal Group

Chanchal Kumar is a prominent Senior Data Science Leader currently serving as the Head of Bioinformatics and Disease Understanding at the Grünenthal Group, based in Cambridge, England. With over 15 years of experience in the field, he has developed a strong background in bioinformatics, translational sciences, and computational biology.

Professional Experience

Grünenthal Group (September 2021 - Present)
- As Head of Bioinformatics and Disease Understanding, Kumar leads initiatives focused on understanding diseases through bioinformatics approaches.
AstraZeneca (2015 - 2021)
- Held multiple roles including Associate Director in Early Cardiovascular, Renal and Metabolism (CVRM) Translational Sciences. He was instrumental in defining bioinformatics strategies and led projects aimed at cardiovascular diseases and type 2 diabetes.
Merck (2011 - 2012)
- Worked as a Senior Scientist in Computational Biology, where he led efforts in translational research and data integration across various 'omics' disciplines.
IBM (2004 - 2005)
- Started his career as a Software Engineer, focusing on bioinformatics and healthcare applications.

Education

PhD in Proteomics and Bioinformatics from the Max Planck Institute of Biochemistry (2005 - 2008).
Postgraduate Diploma in Bioinformatics from the Institute of Bioinformatics and Applied Biotechnology (2003 - 2004).
Bachelor of Information Technology from Delhi Vishwavidyalaya (1998 - 2002).

Kumar's expertise lies in integrating complex biological data to drive innovative solutions in drug discovery and disease understanding. His work emphasizes the application of systems biology and 'omics' technologies to enhance precision medicine approaches.